Golimumab in patients with active rheumatoid arthritis who have previous experience with tumour necrosis factor inhibitors: results of a long-term extension of the randomised, double-blind, placebo-controlled GO-AFTER study through week 160

Golimumab in patients with active rheumatoid arthritis who have previous experience with tumour necrosis factor inhibitors: results of a long-term extension of the randomised, double-blind, placebo-controlled GO-AFTER study through week 160

Bibliographic Details
Main Authors: Smolen, Josef S, Kay, Jonathan, Landewé, Robert B M, Matteson, Eric L, Gaylis, Norman, Wollenhaupt, Jurgen, Murphy, Frederick T, Zhou, Yiying, Hsia, Elizabeth C, Doyle, Mittie K
Format: Online
Language:English
Published: BMJ Group 2012
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3439650/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3439650/

Similar Items